Apollo Technologies was founded in 2022 to put patients at the center of healthcare and simplify a complex and bureaucratic system.
Using artificial intelligence, the company provides doctors and pharmacists with tools that improve efficiency and accessibility.
The company refines its solutions based on real-world feedback from doctors and pharmacists. By combining advanced technology with practical medical needs, Apollo Technologies delivers reliable, regulatory-compliant solutions that optimize clinical decisions and improve patient care.
The main products are Diabeta, a digital solution for diabetologists, Pharmachat and Chat4Doc, which support healthcare professionals in making treatment decisions.
Diabeta is an AI-based digital solution designed to support diabetologists with instant access to official protocols, treatment guidelines and drug interactions. It simplifies access to essential information, reducing administrative burdens and the risk of errors. It also integrates adverse reaction reporting, ensuring regulatory compliance. Through secure access, physicians can receive real-time answers, improving efficiency and patient care. Diabeta optimizes clinical decision-making and makes essential medical data easily accessible, contributing to better outcomes for patients with diabetes.
1) Innovation Ecosystem
2) Test before invest
3) Access to finance
4) Digital culture & skills
Digitalization Solutions